The University of Hong Kong (HKU) announced it had established a biotechnology innovation platform in Zhongshan (Guangdong province, China). New biotech platform is established in cooperation with the Guangdong Pharmaceutical University.
The platform is expected to become a national-level technology startup incubator. It aims to host at least 50 spinoff companies and commercialize the results of at least 10 HKU research projects within five years.
Andy Hor Tzi-sum, vice-president and pro-vice-chancellor (research) at HKU – who is in charge of the project – told the platform is the university’s first-ever biotech cooperation project on the mainland.
The platform will focus on key areas including cancer treatment, medical devices and infectious disease treatment. Located at the Torch High-Tech Industrial Zone, a national health technology park in Zhongshan city, Guangdong province, the platform will have three core units – incubation facility, joint-laboratory and technology transfer unit.